Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Rivaroxaban 20 mg Film-coated Tablets in Healthy Thai Volunteers
TCTR20220723002Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rivaroxaban (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on TCTR20220723002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220723002.